다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
European journal of pharmacology, v.413 no.2/3, 2001년, pp.213 - 219
Burnet, Philip W.J (University Department of Psychiatry, Warneford Hospital, Neuroscience Building, Headington, Oxford OX3 7JX, UK) , Miller, Rowan (University Department of Psychiatry, Warneford Hospital, Neuroscience Building, Headington, Oxford OX3 7JX, UK) , Lewis, Louise J (University Department of Psychiatry, Warneford Hospital, Neuroscience Building, Headington, Oxford OX3 7JX, UK) , Pei, Qi (University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK) , Sharp, Trevor (University Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK) , Harrison, Paul J (University Department of Psychiatry, Warneford Hospital, Neuroscience Building, Headington, Oxford OX3 7JX, UK)
AI-Helper
AbstractRecent studies have suggested that the substance P (tachykinin NK1) receptor may be a pharmacological target for the treatment of mood disorders. Here, the effects of electroconvulsive shock on tachykinin NK1 receptor gene expression in the rat brain was investigated. Rats received either a ...
Neuroscience Beaujouan 18 857 1986 10.1016/0306-4522(86)90105-3 Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain
Am. J. Psychiatry Bremner 157 115 2000 10.1176/ajp.157.1.115 Hippocampal volume reduction in major depression
Acta Physiol. Scand. Brodin 136 613 1989 10.1111/j.1748-1716.1989.tb08710.x Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and sub chronic treatment with a serotonin uptake inhibitor
Biol. Psychiatry Burnet 47 1 80 2000 10.1016/S0006-3223(99)00264-4 Substance P(NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia
Brain Res. Burnet 638 311 1994 10.1016/0006-8993(94)90664-5 The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2A receptors and the abundance of 5-HT receptor and transporter mRNA in the cortex, hippocampus, and dorsal raphe of three strains of rat
Neuropsychopharmacology Burnet 14 442 1996 10.1016/S0893-133X(96)00053-X 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia
Neurochem. Int. Burnet 30 565 1997 10.1016/S0197-0186(96)00124-6 [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia
Neurosci. Lett. Burnet 277 79 1999 10.1016/S0304-3940(99)00857-5 Expression of 5-HT receptors and the 5-HT transporter in the rat brain after electroconvulsive shock
Nature De Felipe 392 394 1998 10.1038/32904 Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
Mol. Psychiatry Drevets 3 220 1998 10.1038/sj.mp.4000370 Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders
Naunyn-Schmeideberg's Arch. Pharmacol. Feuerstein 354 318 1996 10.1007/BF00170837 Modulation of cortical acetylcholine release: the role of substance P interneurons
Psychopharmacology File 152 105 2000 10.1007/s002130000513 NKP608, a NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats
Mol. Pharmacol. Fong 41 24 1992 Differential activation of intracellular effector by two isoforms of human Neurokinin-1 receptor
NeuroReport Gavioli 10 3399 1999 10.1097/00001756-199911080-00026 Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus
Br. J. Pharmacol. Goodwin 83 235 1984 10.1111/j.1476-5381.1984.tb10140.x 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice
J. Biol. Chem. Grady 6 509 1995 Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor
NeuroReport Haddjeri 11 1323 2000 10.1097/00001756-200004270-00035 The effect of neurokinin-1 receptor antagonists on the function of 5-HT and noradrenaline neurons
J. Biol. Chem. Hershey 266 4366 1991 10.1016/S0021-9258(20)64331-9 Organisation, structure, and expression of the gene encoding the rat substance P receptor
Neuropharmacology Jones 24 627 1985 10.1016/0028-3908(85)90104-2 Neuronal sensitivity to substance P is increased after repeated treatment with tranylcypromine, carbamzepine or oxaprotaline, but decreased after repeated electroconvulsive shock
J. Neurochem. Khawaja 64 2716 1995 10.1046/j.1471-4159.1995.64062716.x Characterisation of the binding of [3H]-WAY 100,635, a novel 5-hydroxytryptaimne1A receptor antagonist, to rat brain
Science Kramer 281 1640 1998 10.1126/science.281.5383.1640 Distinct mechanism for antidepressant activity by blockade of central substance P receptors
Mol. Brain Res. Maeno 18 43 1993 10.1016/0169-328X(93)90172-L Distribution of the substance P receptor (NK1 receptor) in the central nervous system
J. Biol. Chem. McConalogue 274 16257 1999 10.1074/jbc.274.23.16257 Substance P induced trafficking of beta arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor
Psychol. Med. Mervaala 30 117 2000 10.1017/S0033291799001567 Quantitative MRI of the hippocampus and amygdala in severe depression
Nature Murtra 405 180 2000 10.1038/35012069 Rewarding effects of opiates are absent in mice lacking the receptor for substance P
NeuroReport Pei 9 391 1998 10.1097/00001756-199802160-00006 Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock
Eur. J. Pharmacol. Roth 207 169 1991 10.1016/0922-4106(91)90093-W Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels
Brain Res. Shirayama 739 70 1996 10.1016/S0006-8993(96)00812-8 Reduction of substance P after chronic antidepressant treatment in the striatum, substantia nigra and amygdala of the rat
Psychopharmacology (Berlin) Smith 120 333 1995 10.1007/BF02311181 Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat
Brain Res. Stenfors 698 39 1995 10.1016/0006-8993(95)00784-N Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli
J. Clin. Psychiatry Taylor 56 Suppl. 6 3 1995 Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug
J. Biol. Chem. Yokota 264 17649 1989 10.1016/S0021-9258(19)84619-7 Molecular characterisation of a functional cDNA for rat substance P receptor
Eur. J. Pharmacol. Zachrisson 319 191 1997 10.1016/S0014-2999(96)00861-8 Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific regions of the rat striatum after electroconvulsive stimuli
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.